Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
European Heart Journal|March 20, 2026
Genetic counselling implementation in dilated cardiomyopathyJob A J Verdonschot, Karin Y van Spaendonck-Zwarts, Debby M E I Hellebrekers, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
European Heart Journal|January 25, 2015
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersAditya Bhonsale, Judith A Groeneweg, Cynthia A James, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
European Heart Journal|May 3, 2018
A common co-morbidity modulates disease expression and treatment efficacy in inherited cardiac sodium channelopathyMathilde R Rivaud, John A Jansen, Pieter G Postema, et al.
European Journal of Heart Failure|April 23, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.
European Journal of Heart Failure|September 12, 2025
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathySophie L V M Stroeks, Ping Wang, Marco Merlo, et al.
Pageof 21